JENNIFER RETIKIS: Open Payments
NPI 1578116851 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 23 payments from 10 companies in 2025. Trend: 2023 $48 · 2024 $296 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $51 |
| Amgen Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: LOKELMA, LEQVIO, VERQUVO, FUROSCIX, REPATHA, JARDIANCE, VYNDAQEL, NEXLETOL.
Industry payments across FL — which companies pay providers there.
